(1) Background: A non-progressive congenital ataxia (NPCA) phenotype caused by β-III spectrin () mutations has emerged, mimicking spinocerebellar ataxia, autosomal recessive type 14 (SCAR14). The pattern of inheritance, however, resembles that of autosomal dominant classical spinocerebellar ataxia type 5 (SCA5). (2) Methods: In-depth phenotyping of two boys studied by a customized gene panel. Candidate variants were sought by structural modeling and protein expression. An extensive review of the literature was conducted in order to better characterize the -associated NPCA. (3) Results: Patients exhibited an NPCA with hypotonia, developmental delay, cerebellar syndrome, and cognitive deficits. Both probands presented with progressive global cerebellar volume loss in consecutive cerebral magnetic resonance imaging studies, characterized by decreasing midsagittal vermis relative diameter measurements. Cortical hyperintensities were observed on fluid-attenuated inversion recovery (FLAIR) images, suggesting a neurodegenerative process. Each patient carried a novel de novo substitution: c.193A > G (p.K65E) or c.764A > G (p.D255G). Modeling and protein expression revealed that both mutations might be deleterious. (4) Conclusions: The reported findings contribute to a better understanding of the -associated phenotype. The mutations may preclude proper structural organization of the actin spectrin-based membrane skeleton, which, in turn, is responsible for the underlying disease mechanism.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958857 | PMC |
http://dx.doi.org/10.3390/ijms22052505 | DOI Listing |
J Neurointerv Surg
December 2024
Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
Background: Rete middle cerebral artery (MCA) is a rare anomaly of the intracranial circulation that mimics congenital Moyamoya disease (MMD). Similar to MMD, it is reported almost exclusively in East-Asian ethnicities. Here, we report 13 patients with rete MCA anomaly from a predominantly non-Asian background in the USA.
View Article and Find Full Text PDFCureus
October 2024
Department of Pediatrics, Maternity and Children Hospital, Bisha, SAU.
Agenesis of the corpus callosum (AgCC) is a rare congenital brain anomaly characterized by the partial or complete absence of the corpus callosum, a crucial structure responsible for interhemispheric communication. Neurological outcomes associated with AgCC vary widely, with presentation ranging from severe intellectual disabilities to normal cognitive function. The condition is often discovered incidentally due to the variability in its clinical presentation.
View Article and Find Full Text PDFExp Mol Med
November 2024
Korea Mouse Phenotyping Center, Seoul National University, Seoul, Republic of Korea.
Int J Mol Sci
October 2024
Department of Human Genetics, Ruhr-University Bochum, 44801 Bochum, Germany.
Pathogenic variants in the ryanodine receptor 1 () gene are causative for a wide spectrum of muscular phenotypes, ranging from malignant hyperthermia over mild, non-progressive to severe congenital myopathy. Both autosomal dominant and recessive inheritance can occur, with the more severe forms usually showing recessive inheritance. However, genotype-phenotype correlations are complicated due to the large size of the gene and heterogeneous phenotypes.
View Article and Find Full Text PDFJ Transl Med
September 2024
Department of Orthopedics, Binhai County People's Hospital, Binhai, Jiangsu Province, 224500, P. R. China.
Congenital myopathies (CMs) are a kind of non-progressive or slow-progressive muscle diseases caused by genetic mutations, which are currently defined and categorized mainly according to their clinicopathological features. CMs exhibit pleiotropy and genetic heterogeneity. Currently, supportive treatment and pharmacological remission are the mainstay of treatment, with no cure available.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!